15:53 IST
NSE
Results Update
Mankind Pharma Results Update
Mankind Pharma reported Q1 FY27 revenue of ₹4,031 crore, up 12.9% YoY. EBITDA grew 24.7% to ₹1,060 crore, with a margin of 26.3%.
Mankind Pharma Ltd
- Share price
- ₹2,500.00
- Market cap
- ₹1,03,261 Cr
- Revenue (annual)
- ₹14,278 Cr
- Net profit (annual)
- ₹1,913 Cr
- P/E (TTM)
- 50.5×Sector 47.3×
- Promoter holding
- 72.63%-0.03% QoQ
- FII holding
- 9.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 10Employee Stock Options 6Other Announcement 5Annual General Meeting 5Management Change 4Earnings Call 4Financial Results 3Debt & Borrowing 3Results Update 2Credit Rating 2Board Meeting Date 2Share Pledge 1Partnership 1Business Update 1Acquisition 1
Time
2 announcements with these filters
20:06 IST
BSE
Results Update
Mankind Pharma Results Update
Mankind Pharma reported FY26 revenue of ₹14,278 Crore, up 17% YoY. Q4FY26 adjusted EBITDA margins reached 27.1%, driven by strong domestic chronic and OTC growth.
- Value
- ₹14,278 Cr